Difluoroethyl-oxazole substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists
US9676761B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2014 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Jun 24, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to difluoroethyl-oxazole substituted bridged spiro[2.4] heptane derivatives of formula (I),wherein the substituents at the piperidine ring are in trans-arrangement, their preparation and their use as pharmaceutically active compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.